Terms: = Head and neck cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Clinical Outcome
15 results:
1. Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma.
de Carvalho AC; Perdomo S; Dos Santos W; Fernandes GC; de Jesus LM; Carvalho RS; Scapulatempo-Neto C; de Almeida GC; Sorroche BP; Arantes LMRB; Melendez ME; De Marchi P; Hayes N; Reis RM; Carvalho AL
Sci Rep; 2020 Jun; 10(1):9970. PubMed ID: 32561788
[TBL] [Abstract] [Full Text] [Related]
2. The high expression of FOXA1 is correlated with a favourable prognosis in salivary duct carcinomas: a study of 142 cases.
Urano M; Hirai H; Tada Y; Kawakita D; Shimura T; Tsukahara K; Kano S; Ozawa H; Okami K; Sato Y; Fushimi C; Shimizu A; Takase S; Okada T; Sato H; Imanishi Y; Otsuka K; Watanabe Y; Sakai A; Ebisumoto K; Togashi T; Ueki Y; Ota H; Sato Y; Saigusa N; Nakaguro M; Hanazawa T; Nagao T
Histopathology; 2018 Dec; 73(6):943-952. PubMed ID: 29993139
[TBL] [Abstract] [Full Text] [Related]
3. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
[TBL] [Abstract] [Full Text] [Related]
4. Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function.
Choi M; Kadara H; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Kim K; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Herbst RS; Wistuba II
Ann Oncol; 2017 Jan; 28(1):83-89. PubMed ID: 28177435
[TBL] [Abstract] [Full Text] [Related]
5. Expression of p27 and pten and clinical characteristics in early laryngeal squamous cell carcinoma and their correlation with recurrence.
Yang JQ; Liang Z; Wu M; Sun YM; Liu HX
Int J Clin Exp Pathol; 2015; 8(5):5715-20. PubMed ID: 26191286
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern cooperative oncology group E2303.
Psyrri A; Lee JW; Pectasides E; Vassilakopoulou M; Kosmidis EK; Burtness BA; Rimm DL; Wanebo HJ; Forastiere AA
Clin Cancer Res; 2014 Jun; 20(11):3023-32. PubMed ID: 24700741
[TBL] [Abstract] [Full Text] [Related]
7. Is biomarker research advancing in the era of personalized medicine for head and neck cancer?
Yokota T
Int J Clin Oncol; 2014 Apr; 19(2):211-9. PubMed ID: 24442754
[TBL] [Abstract] [Full Text] [Related]
8. PI3K/pten/AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel.
Pfisterer K; Fusi A; Klinghammer K; Knödler M; Nonnenmacher A; Keilholz U
Head Neck; 2015 Apr; 37(4):471-8. PubMed ID: 24421178
[TBL] [Abstract] [Full Text] [Related]
9. Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance.
Chang KY; Tsai SY; Chen SH; Tsou HH; Yen CJ; Liu KJ; Fang HL; Wu HC; Chuang BF; Chou SW; Tang CK; Liu SY; Lu PJ; Yen CY; Chang JY
J Biomed Sci; 2013 Jun; 20(1):43. PubMed ID: 23806066
[TBL] [Abstract] [Full Text] [Related]
10. Correlation of immunohistochemical markers and BRAF mutation status with histological variants of papillary thyroid carcinoma in the Korean population.
Min HS; Lee C; Jung KC
J Korean Med Sci; 2013 Apr; 28(4):534-41. PubMed ID: 23580256
[TBL] [Abstract] [Full Text] [Related]
11. Epidermal growth factor receptor, phosphatidylinositol-3-kinase catalytic subunit/pten, and KRAS/NRAS/BRAF in primary resected esophageal adenocarcinomas: loss of pten is associated with worse clinical outcome.
Bettstetter M; Berezowska S; Keller G; Walch A; Feuchtinger A; Slotta-Huspenina J; Feith M; Drecoll E; Höfler H; Langer R
Hum Pathol; 2013 May; 44(5):829-36. PubMed ID: 23158210
[TBL] [Abstract] [Full Text] [Related]
12. Molecular biology of thyroid cancer initiation.
Riesco-Eizaguirre G; Santisteban P
Clin Transl Oncol; 2007 Nov; 9(11):686-93. PubMed ID: 18055323
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic significance of pten expression in esophageal squamous cell carcinoma from Linzhou City, a high incidence area of northern China.
Chang D; Wang TY; Li HC; Wei JC; Song JX
Dis Esophagus; 2007; 20(6):491-6. PubMed ID: 17958724
[TBL] [Abstract] [Full Text] [Related]
14. Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer.
Yu Z; Weinberger PM; Sasaki C; Egleston BL; Speier WF; Haffty B; Kowalski D; Camp R; Rimm D; Vairaktaris E; Burtness B; Psyrri A
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):553-8. PubMed ID: 17372251
[TBL] [Abstract] [Full Text] [Related]
15. Loss of pten expression as a prognostic marker for tongue cancer.
Lee JI; Soria JC; Hassan KA; El-Naggar AK; Tang X; Liu DD; Hong WK; Mao L
Arch Otolaryngol Head Neck Surg; 2001 Dec; 127(12):1441-5. PubMed ID: 11735811
[TBL] [Abstract] [Full Text] [Related]
